Latin America Pharmaceutical Glass Vials And Ampoules Market

Latin America Pharmaceutical Glass Vials And Ampoules Market Analysis

The Latin America Pharmaceutical Glass Vials And Ampoules Market size is worth USD 267.53 Million in 2025, growing at an 8.06% CAGR and is forecast to hit USD 394.19 Million by 2030.

In the pharmaceutical industry, glass vials and ampoules play a pivotal role in primary packaging needs. They provide a chemically stable and inert packaging solution, ensuring the integrity of sensitive medications. Their moisture barrier properties protect these medications from contamination and degradation, fueling the market’s growth.

•For the pharmaceutical industry, enhancing access to innovative medicines in Latin America stands as a top priority. Data from the International Trade Administration reveals that Brazil, the region's largest healthcare market, allocates 9.47% of its GDP, equating to a substantial USD 161 billion in healthcare expenditures, fueling notable market growth.

•The COVID-19 pandemic underscored the critical role of glass packaging, especially for vaccine distribution, leading to a pronounced uptick in vial demand. As reported by the Brazilian Ministry of Health, over 37.8 million Brazilians contracted COVID-19, with 98% of adults receiving at least their first vaccine dose and 86% being fully vaccinated, further driving market expansion.

•In response to this surging demand, glass vial and ampoule manufacturers, such as Gerresheimer AG, ramped up their production capabilities in the region. For example, in November 2023, Gerresheimer AG, hailing from Germany, broke ground on an expansion at its Querétaro, Mexico facility. This new production line is set to bolster the company's output of syringes, vials, and ampoules, primarily targeting the North American market.

•Yet, challenges loom. Glass, being heavier than plastic, incurs steeper production and shipping costs. This weightiness not only amplifies transportation expenses within the supply chain but also heightens the risk of breakage during transit, potentially dampening product demand across Latin America.

Latin America Pharmaceutical Glass Vials And Ampoules Market Trends

The Vials Segment is Estimated to Have the Largest Market Share

• •Glass vials, typically shaped like tubes with flat bottoms, are essential for storing medicines and laboratory samples. In Latin American countries, including Brazil, Mexico, and Argentina, the pharmaceutical sector's specific storage and handling requirements drive the demand for vials with various caps.
• Glass vials are increasingly favored for their chemical resistance, which protects liquid drug formulas during storage and transportation. The availability of pre-sterilized and pre-washed vials in secondary packaging adds convenience, further fueling the market’s growth in the region's pharmaceutical sector.
• Regional manufacturers such as Gerresheimer AG, Stevanato Group, and SDG SA offer a diverse range of glass vials, spanning types I, II, and III, and sizes from 0.6 to 100 ml, specifically for the pharmaceutical industry. Moreover, these manufacturers are committed to producing custom-tailored vials to meet individual customer needs.
• Brazil's burgeoning pharmaceutical industry significantly boosts the demand for glass vials. Data from the International Trade Administration highlights Brazil's global prominence, ranking sixth in drugs and pharmaceuticals. Pharmaceutical sales surged from USD 16.38 billion in 2021 to USD 24 billion in 2023, underscoring the industry's robust growth.

Brazil is Expected to Hold High Market Share

• The Brazilian pharmaceutical industry is rapidly expanding, largely due to its aging population. Data from GMDP Academy reveals a 57% increase in the population aged 65 and above, jumping from 14.1 million in 2010 to 22.2 million in 2023. This demographic now makes up 11% of Brazil's total population, a shift likely to boost the demand for glass vials and ampoules in the nation.
• Another driving force behind Brazil's market growth is its expanding domestic manufacturing capacity for medicines and drugs. The International Trade Administration highlights Brazil's significance: it boasts the world's largest government-run public healthcare system, stands as the region's largest economy, and leads South America with an annual pharmaceutical sales figure of approximately USD 14.7 billion.
• Brazilian manufacturers, such as Nipro Corporation, are ramping up production of glass packaging products, including vials and ampoules, to meet the surging demand. These manufacturers are diversifying their offerings, providing vials and ampoules in various shapes and sizes tailored for the pharmaceutical sector.
• Brazil's increasing imports of glass ampoules, prized in the pharmaceutical sector for their durability and transparency, further fuel the market's growth. Data from the International Trade Center (ITC) indicates a rise in Brazil's import value of glass ampoules, climbing from USD 4.07 million in 2021 to USD 7.34 million in 2023. Mexico and China emerge as the primary import sources for Brazil.

Latin America Pharmaceutical Glass Vials And Ampoules Industry Overview

Key players, including Nipro Corporation, Stevanato Group, Gerresheimer AG, and SGD SA, dominate the Latin American pharmaceutical glass vials and ampoules market, competing for a larger share. These industry leaders strategically channel investments into new product development, pursue mergers and acquisitions, and expand geographically to bolster their presence in Latin America.

Latin America Pharmaceutical Glass Vials And Ampoules Market Leaders

Latin America Pharmaceutical Glass Vials And Ampoules Market News

• May 2024: Stevanto Group, an Italian glass manufacturer with operations in Latin America, inaugurated a state-of-the-art facility in Cisterna di Latina dedicated to producing pre-sterilized vials, cartridges, and syringes. Equipped with cutting-edge production lines, the new plant is strategically positioned to address the evolving demands of Europe's expanding pharmaceutical packaging market.
• January 2024: Scott Pharma, headquartered in Germany and operations in Brazil, launched its Everic freeze vials. These vials are engineered for the ultra-cold storage of mRNA and gene therapy medications, capable of enduring temperatures plummeting to -80 degrees, thus averting glass breakage. The company is primarily concentrating on broadening its product range to cater to deep-cold storage needs.